In obesity and type 2 diabetes mouse models, the β3-AR/eNOS/NO pathway is defective; therefore, BRL37344, as well as epinephrine, show no effect on both infarct size and eNOS expression. The gene discussed is ADRB3; the disease is type 2 diabetes mellitus.